Seraphina Therapeutics is a pioneering health and wellness company based in San Diego, co-founded by Drs. Stephanie and Eric Venn-Watson. The company is dedicated to advancing global health through the discovery and development of essential fatty acids and micronutrient therapeutics. Their flagship discovery is C15:0 (pentadecanoic acid), the first essential fatty acid identified in over 90 years, which has shown promise in promoting healthy aging and cellular resilience.